Clinical Trial: Integrating Clinical, Protein Expression, and Genetic Markers to Predict Lymphedema in Breast Cancer

U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07252843) titled 'Integrating Clinical, Protein Expression, and Genetic Markers to Predict Lymphedema in Breast Cancer' on Nov. 19.

Brief Summary: The goal of this observational ambidirectional cohort study is to develop a prediction model to identify the risk of lymphedema after axillary lymph node dissection (ALND) in patients with breast cancer. The main questions it aims to answer are:

* Can clinicopathological factors predict the development of lymphedema?

* Do protein expression profiles and genetic mutations increase susceptibility to lymphedema?

Participants will:

* Undergo clinical evaluation and indocyanine green (ICG) lymphography to d...